Carmat said the device includes a wearable communication system that
provides patients information and relays telediagnostic data to the
hospital for remote follow-up of patients.
The company noted that the
first generation of lithium-ion batteries enables patients to return
home under good conditions with a portable system carried on a trolley
or on the patient’s shoulder. This will soon be replaced by a second
generation using fuel cells worn directly by the patient.
story started twenty years ago when Professor Alain Carpentier, known
for his invention of Carpentier-Edwards heart valves, asked aeronautics
and space engineers from the MATRA group, now a subsidiary of EADS, to
develop a long-lasting physiological solution that would
save thousands of patients condemned to a very short life expectancy
because of a lack of available heart transplants or because of a
contraindication to transplantation.
alliance developed what they claim is the first “embedded biomimetic
heart” optimized in terms of volume, weight and energy.
With the backing
of the European Commission, Carmat said it has received 33 million euros
($42 million), the largest subsidy ever given to an SME by the French
Agency for Innovation (OSEO).
Click on image to watch a video